Previous 10 | Next 10 |
Are These The Top Biotech Stocks To Watch Now? 3 To Consider Biotech stocks are still amongst the top performers on the stock market as we started off 2021. With numerous life-threatening diseases still running amok, there is a grave need for the treatments these companies d...
It's hard to think of an industry that was more impacted by the 2020 COVID pandemic than diagnostics. The often-overlooked part of the healthcare system sprang into action, testing more than 250 million people last year in the U.S. alone. And interestingly, some testing companies performed ...
Co-Diagnostics to Present at H.C. Wainwright BioConnect 2021 Virtual Conference PR Newswire SALT LAKE CITY , Jan. 7, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented plat...
Citing preliminary internal financial reporting, Co-Diagnostics ([[CODX]] -0.9%) says it expects Q4 2020 revenue to be the highest quarterly revenue in the company’s history.Estimating a 20 – 25% growth over the Q3 2020 revenue of $21.8M, the revenue projecte...
Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic Products PR Newswire SALT LAKE CITY , Jan. 6, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics com...
Three referenced quant rating categories (value, growth, and profitability) are significant considerations in selecting healthcare investments. The data underlying the value, growth, and profitability tabs runs a significant gamut of the information properly considered in performing d...
Co-Diagnostics (CODX) has announced it has completed the principal design work for a PCR test to detect several mutations in the newly detected variant of SARS-CoV-2 known as VUI 202012/01.The new test will be a separate product, the company said, confirming that the mutations in th...
Co-Diagnostics Designs Test to Detect Mutations for New Coronavirus Strain Using CoPrimer™ Platform Proprietary Company design process facilitates rapid response in detecting mutation of a new coronavirus strain circulating in the UK PR Newswire SALT LAKE CI...
Do You Have These Top Biotech Stocks On Your End Of Year Watchlist? Biotech stocks are at the center of attention this year in the stock market and will likely still be in 2021. This is because many of these biotech companies were trying to develop vaccines and treatments fo...
The Premium Portfolio has gained +44.54% YTD compared to the S&P 500 +14.81% YTD beating the index by +29.7% with one week to go. The Premium Portfolio has beaten the S&P 500 every year since inception with 32% avg annual returns from 20.8% in 2018, 30.7% in 2019. Weekly r...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...